Envoy Medical (COCH) Shares Outstanding (2020 - 2026)

Envoy Medical has disclosed Shares Outstanding (Entity) across 7 years of filings, most recently posting $104.0 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 383.43% year-over-year to $104.0 million; the TTM figure through Jun 2026 stood at $104.0 million (up 383.43% YoY), while the FY2025 annual figure was $33.1 million, down 3.62% from the prior year.
• Shares Outstanding (Entity) came in at $104.0 million for Q2 2026 at Envoy Medical, up from $76.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $104.0 million in Q2 2026 to a low of $19.3 million in Q2 2023.
• Average Shares Outstanding (Entity) over 5 years is $48.5 million, with a median of $33.1 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) plunged 79.87% in 2023 and soared 383.43% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $53.1 million in 2022, then plunged by 54.64% to $24.1 million in 2023, then surged by 42.34% to $34.3 million in 2024, then retreated by 3.62% to $33.1 million in 2025, then surged by 214.68% to $104.0 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $104.0 million in Q2 2026, $76.9 million in Q1 2026, and $33.1 million in Q4 2025.